Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Med Okayama ; 65(6): 407-11, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22189482

ABSTRACT

Mediastinal lymph node carcinoma of unknown primary site is rare and may have a better prognosis if extensive treatment is performed. Case, A 69-year-old-male presented with a persistent cough. Chest computed tomography (CT) demonstrated a large tumor 9.5 × 8.2 cm, in the mediastinum, compressing the right main bronchus, the right pulmonary artery, and the superior vena cava. Because fiberoptic bronchoscopy was insufficient for diagnosis, mediastinoscopic tumor biopsy under general anesthesia was undertaken. Histological examination revealed adenocarcinoma. Extensive examinations revealed no other neoplastic lesion except in the mediastinum. Mediastinal lymph node carcinoma of unknown primary site was diagnosed. The patient was treated with docetaxel and cisplatin with concurrent thoracic radiation therapy. A month after the start of chemoradiotherapy, the mediastinal tumor regressed markedly. The patient remained free of symptoms without regrowth of the primary site. Exploration of the body showed no further abnormalities 20 months after disease onset.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma , Cisplatin/therapeutic use , Mediastinal Neoplasms , Neoplasms, Unknown Primary , Taxoids/therapeutic use , Aged , Carcinoma/drug therapy , Carcinoma/pathology , Carcinoma/radiotherapy , Chemoradiotherapy , Docetaxel , Humans , Lymph Nodes/pathology , Male , Mediastinal Neoplasms/drug therapy , Mediastinal Neoplasms/pathology , Mediastinal Neoplasms/radiotherapy , Mediastinum/pathology , Neoplasms, Unknown Primary/drug therapy , Neoplasms, Unknown Primary/pathology , Neoplasms, Unknown Primary/radiotherapy , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...